Chemokine receptor CXCR3 mediates T cell recruitment and tissue injury in nephrotoxic nephritis in mice

Journal of the American Society of Nephrology

Volumn 18, Issue 7, 2007, Pages 2071-2084

  Panzer, Ulf ^a   Steinmetz, Oliver M ^a   Paust, Hans Joachim ^a   Meyer Schwesinger, Catherine ^a   Peters, Anett ^a   Turner, Jan Eric ^a   Zahner, Gunther ^a   Heymann, Felix ^b   Kurts, Christian ^b   Hopfer, Helmut ^a   Helmchen, Udo ^a   Haag, Friedrich ^a   Schneider, André ^a   Stahl, Rolf A K ^a,c  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5 ANTAGONIST; CHEMOKINE RECEPTOR CXCR3; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN G; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; RANTES;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; CELL INFILTRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; GENE EXPRESSION; GLOMERULUS; HUMORAL IMMUNITY; IMMUNE COMPLEX NEPHRITIS; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; INFLAMMATORY DISEASE; KIDNEY FUNCTION; KIDNEY TUBULE ABSORPTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; TH1 CELL; TH2 CELL; TISSUE INJURY; WILD TYPE;

EID: 34447265780     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006111237     Document Type: Article

References (39)

1. Rees AJ: The role of infiltrating leukocytes in progressive renal disease: Implications for therapy. Nat Clin Pract Nephrol 2: 348-349, 2006
2. Tipping PG, Holdsworth SR: T cells in crescentic glomerulonephritis. J Am Soc Nephrol 17: 1253-1263, 2006
3. Charo IF, Ransohoff RM: The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354: 610-621, 2006
4. Moser B, Wolf M, Walz A, Loetscher P: Chemokines: Multiple levels of leukocyte migration control. Trends Immunol 25:75-84, 2004
5. Sallusto F, Lanzavecchia A: Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol Rev 177: 134-140, 2000
6. Kim CH: Chemokine-chemokine receptor network in immune cell trafficking. Curr Drug Targets Immune Endocr Metabol Disord 4: 343-361, 2004
7. Kelley VR, Rovin BH: Chemokines: Therapeutic targets for autoimmune and inflammatory renal disease. Springer Semin Immunopathol 24: 411-421, 2003
8. Panzer U, Steinmetz OM, Stahl RA, Wolf G: Kidney diseases and chemokines. Curr Drug Targets 7: 65-80, 2006
9. Anders HJ, Vielhauer V, Schlondorff D: Chemokines and chemokine receptors are involved in the resolution or progression of renal disease. Kidney Int 63: 401-415, 2003
10. Holdsworth SR, Kitching AR, Tipping PG: Chemokines as therapeutic targets in renal disease. Curr Opin Nephrol Hypertens 9: 505-511, 2000
11. Wada T, Yokoyama H, Matsushima K, Kobayashi K: Chemokines in renal diseases. Int Immunopharmacol 1: 637-645, 2001
12. Segerer S, Banas B, Wornle M, Schmid H, Cohen CD, Kretzler M, Mack M, Kiss E, Nelson PJ, Schlondorff D, Grone HJ: CXCR3 is involved in tubulointerstitial injury in human glomerulonephritis. Am J Pathol 164: 635-649, 2004
13. Romagnani P, Beltrame C, Annunziato F, Lasagni L, Luconi M, Galli G, Cosmi L, Maggi E, Salvadori M, Pupilli C, Serio M: Role for interactions between IP-10/Mig and CXCR3 in proliferative glomerulonephritis. J Am Soc Nephrol 10: 2518-2526, 1999
14. Panzer U, Steinmetz OM, Reinking RR, Meyer TN, Fehr S, Schneider A, Zahner G, Wolf G, Helmchen U, Schaerli P, Stahl RA, Thaiss F: Compartment-specific expression and function of the chemokine IP-10/CXCL10 in a model of renal endothelial microvascular injury. J Am Soc Nephrol 17: 454-464, 2006
15. Romagnani P, Lazzeri E, Lasagni L, Mavilia C, Beltrame C, Francalanci M, Rotondi M, Annunziato F, Maurenzig L, Cosmi L, Galli G, Salvadori M, Maggi E, Serio M: IP-10 and Mig production by glomerular cells in human proliferative glomerulonephritis and regulation by nitric oxide. J Am Soc Nephrol 13: 53-64, 2002
16. Avihingsanon Y, Phumesin P, Benjachat T, Akkasilpa S, Kittikowit V, Praditpornsilpa K, Wongpiyabavorn J, Eiam-Ong S, Hemachudha T, Tungsanga K, Hirankarn N: Measurement of urinary chemokine and growth factor messenger RNAs: A noninvasive monitoring in lupus nephritis. Kidney Int 69: 747-753, 2006
17. Han GD, Suzuki K, Koike H, Suzuki K, Yoneyama H, Narumi S, Shimizu F, Kawachi H: IFN-inducible protein-10 plays a pivotal role in maintaining slit-diaphragm function by regulating podocyte cell-cycle balance. J Am Soc Nephrol 17: 442-453, 2006
18. Han GD, Koike H, Nakatsue T, Suzuki K, Yoneyama H, Narumi S, Kobayashi N, Mundel P, Shimizu F, Kawachi H: IFN-inducible protein-10 has a differential role in podocyte during Thy 1.1 glomerulonephritis. J Am Soc Nephrol 14: 3111-3126, 2003
19. Liu L, Callahan MK, Huang D, Ransohoff RM: Chemokine receptor CXCR3: An unexpected enigma. Curr Top Dev Biol 68: 149-181, 2005
20. Lazzeri E, Romagnani P: CXCR3-binding chemokines: Novel multifunctional therapeutic targets. Curr Drug Targets Immune Endocr Metabol Disord 5: 109-118, 2005
21. Panzer U, Reinking RR, Steinmetz OM, Zahner G, Sudbeck U, Fehr S, Pfalzer B, Schneider A, Thaiss F, Mack M, Conrad S, Huland H, Helmchen U, Stahl RA: CXCR3 and CCR5 positive T-cell recruitment in acute human renal allograft rejection. Transplantation 78: 1341-1350, 2004
22. Akalin E, Dikman S, Murphy B, Bromberg JS, Hancock WW: Glomerular infiltration by CXCR3+ ICOS+ activated T cells in chronic allograft nephropathy with transplant glomerulopathy. Am J Transplant 3: 1116-1120, 2003
23. Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M, Koch AE, Moser B, Mackay CR: The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 101: 746-754, 1998
24. Balashov KE, Rottman JB, Weiner HL, Hancock WW: CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci U S A 96: 6873-6878, 1999
25. Hancock WW, Lu B, Gao W, Csizmadia V, Faia K, King JA, Smiley ST, Ling M, Gerard NP, Gerard C: Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J Exp Med 192: 1515-1520, 2000
26. Frigerio S, Junt T, Lu B, Gerard C, Zumsteg U, Hollander GA, Piali L: Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. Nat Med 8: 1414-1420, 2002
27. Fiorina P, Ansari MJ, Jurewicz M, Barry M, Ricchiuti V, Smith RN, Shea S, Means TK, Auchincloss H Jr, Luster AD, Sayegh MH, Abdi R: Role of CXC chemokine receptor 3 pathway in renal ischemic injury. J Am Soc Nephrol 17: 716-723, 2006
28. Hancock WW, Gao W, Csizmadia V, Faia KL, Shemmeri N, Luster AD: Donor derived IP-10 initiates development of acute allograft rejection. J Exp Med 193: 975-980, 2001
29. Huang XR, Tipping PG, Shuo L, Holdsworth SR: Th1 responsiveness to nephritogenic antigens determines susceptibility to crescentic glomerulonephritis in mice. Kidney Int 51: 94-103, 1997
30. Kitching AR, Holdsworth SR, Tipping PG: IFN-gamma mediates crescent formation and cell-mediated immune injury in murine glomerulonephritis. J Am Soc Nephrol 10: 752-759, 1999
31. Hurtado A, Johnson RJ: Hygiene hypothesis and prevalence of glomerulonephritis. Kidney Int Suppl 97: S62-S67, 2005
32. Topham PS, Csizmadia V, Soler D, Hines D, Gerard CJ, Salant DJ, Hancock WW: Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis. J Clin Invest 104: 1549-1557, 1999
33. Schadde E, Kretzler M, Banas B, Luckow B, Assmann K, Schlondorff D: Expression of chemokines and their receptors in nephrotoxic serum nephritis. Nephrol Dial Transplant 15: 1046-1053, 2000
34. Fatkenheuer G, Pozniak AL, Johnson MA, Plettenberg A, Staszewski S, Hoepelman AI, Saag MS, Goebel FD, Rockstroh JK, Dezube BJ, Jenkins TM, Medhurst C, Sullivan JF, Ridgway C, Abel S, James IT, Youle M, van der Ryst E: Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1. Nat Med 11: 1170-1172, 2005
35. Kruger T, Benke D, Eitner F, Lang A, Wirtz M, Hamilton-Williams EE, Engel D, Giese B, Muller-Newen G, Floege J, Kurts C: Identification and functional characterization of dendritic cells in the healthy murine kidney and in experimental glomerulonephritis. J Am Soc Nephrol 15: 613-621, 2004
36. Panzer U, Thaiss F, Zahner G, Barth P, Reszka M, Reinking RR, Wolf G, Helmchen U, Stahl RAK: Monocyte chemoattractant protein-1 and osteopontin differentially regulate monocytes recruitment in experimental glomerulonephritis. Kidney Int 59: 1762-1769, 2001
37. Hopfer H, Maron R, Butzmann U, Helmchen U, Weiner HL, Kalluri R: The importance of cell-mediated immunity in the course and severity of autoimmune anti-glomerular basement membrane disease in mice. FASEB J 17: 860-868, 2003
38. Vielhauer V, Anders HJ, Perez de Lema G, Luckow B, Schlondorff D, Mack M: Phenotyping renal leukocyte subsets by four-color flow cytometry: Characterization of chemokine receptor expression. Nephron Exp Nephrol 93: 63-71, 2003
39. 2 modulates the functional responsiveness of human monocytes to chemokines. Eur J Immunol 34: 3682-3689, 2004